Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03161431 |
|---|---|
| Brief Title: | SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab |
| First Submitted : | May 16, 2017 |
| First Submitted that Met QC Criteria : | May 18, 2017 |
| First Posted : | May 19, 2017 |
| Last Update Submitted that Met QC Criteria : | May 9, 2024 |
| Last Update Posted : | May 13, 2024 |